1dd7: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1dd7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dd7, resolution 2.25Å" /> '''MURINE INDUCIBLE NIT...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1dd7.gif|left|200px]]<br /><applet load="1dd7" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1dd7.gif|left|200px]]<br /><applet load="1dd7" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1dd7, resolution 2.25&Aring;" />
caption="1dd7, resolution 2.25&Aring;" />
'''MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) (N-[(1,3-BENZODIOXOL-5-YL)METHYL]-1-[2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL]-4-(METHOXYCARBONYL)-PIPERAZINE-2-ACETAMIDE COMPLEX'''<br />
'''MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) (N-[(1,3-BENZODIOXOL-5-YL)METHYL]-1-[2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL]-4-(METHOXYCARBONYL)-PIPERAZINE-2-ACETAMIDE COMPLEX'''<br />


==Overview==
==Overview==
Potent and selective inhibitors of inducible nitric oxide synthase (iNOS), (EC ) were identified in an encoded combinatorial chemical library that, blocked human iNOS dimerization, and thereby NO production. In a, cell-based iNOS assay (A-172 astrocytoma cells) the inhibitors had, low-nanomolar IC(50) values and thus were &gt;1,000-fold more potent than the, substrate-based direct iNOS inhibitors 1400W and N-methyl-l-arginine., Biochemical studies confirmed that inhibitors caused accumulation of iNOS, monomers in mouse macrophage RAW 264.7 cells. High affinity (K(d), approximately 3 nM) of inhibitors for isolated iNOS monomers was confirmed, by using a radioligand binding assay. Inhibitors were &gt;1,000-fold, selective for iNOS versus endothelial NOS dimerization in a cell-based, assay. The crystal structure of inhibitor bound to the monomeric iNOS, oxygenase domain revealed inhibitor-heme coordination and substantial, perturbation of the substrate binding site and the dimerization interface, indicating that this small molecule acts by allosterically disrupting, protein-protein interactions at the dimer interface. These results provide, a mechanism-based approach to highly selective iNOS inhibition. Inhibitors, were active in vivo, with ED(50) values of &lt;2 mg/kg in a rat model of, endotoxin-induced systemic iNOS induction. Thus, this class of, dimerization inhibitors has broad therapeutic potential in iNOS-mediated, pathologies.
Potent and selective inhibitors of inducible nitric oxide synthase (iNOS) (EC ) were identified in an encoded combinatorial chemical library that blocked human iNOS dimerization, and thereby NO production. In a cell-based iNOS assay (A-172 astrocytoma cells) the inhibitors had low-nanomolar IC(50) values and thus were &gt;1,000-fold more potent than the substrate-based direct iNOS inhibitors 1400W and N-methyl-l-arginine. Biochemical studies confirmed that inhibitors caused accumulation of iNOS monomers in mouse macrophage RAW 264.7 cells. High affinity (K(d) approximately 3 nM) of inhibitors for isolated iNOS monomers was confirmed by using a radioligand binding assay. Inhibitors were &gt;1,000-fold selective for iNOS versus endothelial NOS dimerization in a cell-based assay. The crystal structure of inhibitor bound to the monomeric iNOS oxygenase domain revealed inhibitor-heme coordination and substantial perturbation of the substrate binding site and the dimerization interface, indicating that this small molecule acts by allosterically disrupting protein-protein interactions at the dimer interface. These results provide a mechanism-based approach to highly selective iNOS inhibition. Inhibitors were active in vivo, with ED(50) values of &lt;2 mg/kg in a rat model of endotoxin-induced systemic iNOS induction. Thus, this class of dimerization inhibitors has broad therapeutic potential in iNOS-mediated pathologies.


==About this Structure==
==About this Structure==
1DD7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with SO3, HEM and 1PM as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DD7 OCA].  
1DD7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=SO3:'>SO3</scene>, <scene name='pdbligand=HEM:'>HEM</scene> and <scene name='pdbligand=1PM:'>1PM</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DD7 OCA].  


==Reference==
==Reference==
Line 26: Line 26:
[[Category: nos]]
[[Category: nos]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 13:11:18 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:15:26 2008''